YK11

What Is Dragon Pharma YK-11?

Dragon Pharma YK-11 is a synthetic steroidal SARM (Selective Androgen Receptor Modulator) engineered for serious athletes who demand results beyond what traditional SARMs can deliver. Structurally derived from dihydrotestosterone (DHT), YK-11 operates through a dual anabolic mechanism — binding powerfully to the androgen receptor while simultaneously inhibiting myostatin, the protein that biologically caps your muscle growth potential.

By suppressing myostatin and elevating follistatin expression, Dragon Pharma YK-11 unlocks a level of muscle hypertrophy typically out of reach for non-steroidal SARMs like Ostarine (MK-2866) or LGD-4033. The result: accelerated lean muscle gains, enhanced strength, and a harder, more conditioned physique.

Dragon Pharma YK-11 – Key Benefits

• Myostatin inhibition — removes the biological ceiling on muscle cell size and number
• Powerful androgen receptor binding — drives lean muscle hypertrophy comparable to mild oral steroids
• Increased follistatin expression — supports anabolic signaling beyond standard SARM activity
• Strength and muscle density gains — notable results even in short 4–6 week cycles
• Lean mass retention — effective during recomp and cutting phases when stacked appropriately

Dragon Pharma YK-11 Dosage Guide

Because YK-11 behaves more like an oral anabolic steroid than a traditional SARM, dosing precision is critical. Dragon Pharma YK-11 should always be taken in a split AM/PM protocol to maintain stable blood levels and reduce androgenic and hepatic stress.

Split dosing is mandatory. Example: 5 mg in the morning + 5 mg in the evening for a 10 mg/day protocol. YK-11 is fat-soluble — always take with a meal containing healthy fats for optimal absorption.

Never exceed 15 mg/day. At higher doses, Dragon Pharma YK-11 significantly increases the risk of testosterone suppression, elevated liver enzymes (ALT/AST), and androgenic side effects including acne, oily skin, and hair shedding in genetically predisposed users.

Recommended Cycle Length

Dragon Pharma YK-11 cycles should be kept to a strict 4–6 week window. As a 17-alpha alkylated compound, extended use places disproportionate stress on the liver and suppresses the HPG axis more aggressively than non-methylated SARMs.

• First-time users: 4 weeks at 5–10 mg/day
• Experienced users: up to 6 weeks at 10–15 mg/day
• Always follow with a full 4-week PCT using Clomid (50 mg/day) or Nolvadex (40 mg/day)

Stacking Dragon Pharma YK-11

Dragon Pharma YK-11 is compatible with select compounds for users seeking synergistic results. Stack selection should prioritize managing testosterone suppression and hepatotoxicity.

Best stacks:

• YK-11 + Ostarine (MK-2866): Ideal for lean recomp; Ostarine protects joints and lean mass. Dose: 10–20 mg Ostarine + 5–10 mg YK-11/day.
• YK-11 + MK-677 (Ibutamoren): Non-suppressive GH/IGF-1 elevation, improved recovery and sleep. Dose: 10–20 mg MK-677 + 5–10 mg YK-11/day.
• YK-11 + LGD-4033: Aggressive mass-building stack — use conservatively (max 6 weeks, low doses) due to compounding suppression.

Avoid: RAD-140 + YK-11 (excessive suppression), oral anabolics or prohormones + YK-11 (compounding liver toxicity and hormonal stress).

Post-Cycle Therapy (PCT) After Dragon Pharma YK-11

A PCT is non-negotiable after every Dragon Pharma YK-11 cycle. YK-11 suppresses LH and FSH through negative feedback on the hypothalamic-pituitary-gonadal axis — even at conservative doses. Without proper Post-Cycle Therapy, users risk prolonged low testosterone, loss of cycle gains, mood instability, and sexual dysfunction.

Standard PCT Protocol (Weeks 1–4 post-cycle):

• Clomid: 50 mg/day OR Nolvadex: 40 mg/day
• Liver support: TUDCA and NAC throughout and post-cycle
• Bloodwork at week 4 post-PCT: Total T, Free T, LH, FSH, Estradiol, AST/ALT

Side Effects of YK-11

Dragon Pharma YK-11 is one of the most potent SARMs available and carries a more demanding side effect profile than non-steroidal alternatives. Known risks include:

• Testosterone suppression — clinically significant even at 5–10 mg/day
• Liver stress — 17-alpha alkylation requires liver support (TUDCA, NAC) throughout the cycle
• Androgenic effects — acne, oily skin, accelerated hair loss in predisposed individuals
• Estrogen rebound post-cycle — not from aromatization, but from testosterone crash; controlled with proper PCT

YK-11 is not recommended for women due to strong DHT-like androgenic activity and virilization risk.

Legal Status and Anti-Doping

Dragon Pharma YK-11 is classified as a research chemical and is not approved for human consumption by the FDA. It is explicitly prohibited by WADA under the S1.2 Selective Androgen Receptor Modulators category and will produce a positive doping test.

Dragon Pharma YK-11 is intended for research purposes only. Not for use by tested athletes.

Why Dragon Pharma YK-11?

Dragon Pharma is a globally recognized pharmaceutical-grade manufacturer known for rigorous quality standards, third-party testing, and consistent compound purity. Dragon Pharma YK-11 delivers:

• Verified purity and accurate dosing per capsule/tablet
• Pharmaceutical-grade synthesis consistent with Dragon Pharma's manufacturing standards
• Trusted by bodybuilders and researchers worldwide